Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Frontier Medicines
Biotech
After ‘tough years,’ Frontier is ramping up clinical ambitions
Frontier CEO Chris Varma, Ph.D., told Fierce the biotech's team “have come back from” a tough period and want to ramp up their clinical ambitions.
Will Maddox
Aug 27, 2026 9:50am
'Tough but necessary decision': Frontier Meds lays off staff
Feb 5, 2025 10:52am
AACR: KRAS inhibitors pop in preclinical data debuts
Apr 11, 2024 4:30am
Frontier CEO weathers one of his hardest fundraises to add $80M
Feb 22, 2024 4:01pm
Next round of KRAS drugs follow footsteps of Amgen and Mirati
May 4, 2023 6:00am
Billy Dunn departs FDA—Chutes & Ladders
Mar 3, 2023 9:30am
